Evidence map›Paper›PMID 39010890›Full record

ArticleAcute medicine & surgery

Successful use of methylene blue for catecholamine-refractory vasoplegic shock due to metformin intoxication: A case report and literature review.

Yuji Takahashi, Hidehiko Nakano, Maiko Motoki, Yuji Wakimoto, Daisuke Ikechi, Yasuaki Koyama, Hideki Hashimoto

Abstract readCase Reports
In one paragraph

Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Methylene blue in the critical care setting.World journal of critical care medicine · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuji TakahashiDepartment of Emergency and Critical Care Medicine Hitachi General Hospital Hitachi Ibaraki Japan.ORCID https://orcid.org/0000-0002-9776-2647
Hidehiko NakanoDepartment of Emergency and Critical Care Medicine Hitachi General Hospital Hitachi Ibaraki Japan.ORCID https://orcid.org/0000-0003-1384-634X
Maiko MotokiDepartment of Emergency and Critical Care Medicine Hitachi General Hospital Hitachi Ibaraki Japan.
Yuji WakimotoDepartment of Emergency and Critical Care Medicine Hitachi General Hospital Hitachi Ibaraki Japan.
Daisuke IkechiDepartment of Emergency and Critical Care Medicine Hitachi General Hospital Hitachi Ibaraki Japan.
Yasuaki KoyamaDepartment of Emergency and Critical Care Medicine Hitachi General Hospital Hitachi Ibaraki Japan.
Hideki HashimotoDepartment of Emergency and Critical Care Medicine Hitachi General Hospital Hitachi Ibaraki Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Severe metformin intoxication can lead to lactic acidosis and vasoplegic shock, for which the optimal management strategy remains uncertain, especially in cases of severe circulatory collapse. Case Presentation: A 45-year-old diabetic woman on metformin therapy presented with impaired consciousness and seizures. She had experienced a cardiac arrest and undergone extracorporeal cardiopulmonary resuscitation. Blood gas analysis showed severe lactic acidosis. A 71-g metformin packet was found at the patient's home, suggesting an overdose. Despite extracorporeal support and blood purification, severe lactic acidosis and hypotension persisted. Methylene blue was administered 32 h from the onset, which improved her metabolic and circulatory status. We examined her blood sample throughout the case to check the transition of metformin blood concentration. Conclusion: Methylene blue may be beneficial for severe metformin toxicity, regardless of the blood concentration of metformin and the time since intoxication. However, further research is needed to establish its optimal use and effectiveness.

Indexed as

drug‐related side effects and adverse reactionsmetforminmethylene bluepoisoningvasoplegia

Identifiers

PMID39010890
PMCPMC11247704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.